A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
Clinical trial NCT06106022 · COMPLETED
Trial details
- NCT number
- NCT06106022
- Sponsor
- Phathom Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-04-16
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.